BFC

What BFC does

Baggerman Farma Consult BV (BFC) is a boutique life sciences consultancy founded in 1987 and headquartered in Eindhoven, Netherlands. The firm provides specialized consulting services across Regulatory Affairs, Quality Affairs, and Pharmacovigilance to pharmaceutical companies, medical device manufacturers, and healthcare organizations, serving clients ranging from early-stage biotech startups to established global players. BFC has been delivering pharmacovigilance services since 1992, giving the firm over three decades of operating history in regulated life sciences advisory.

The firm operates on a "Regulatory as a Service" (RaaS) model, deploying a team of 12 experienced senior consultants on a project, embedded, or retained basis. Service offerings have been expanded to include a Market Access Program covering pricing, reimbursement, and health technology assessment support. To extend geographic reach beyond the Dutch market, BFC has partnered with the EUdraCON Network to provide pan-European regulatory coverage. The firm is led by Managing Partner Jens-Erik Vaessen alongside founders Kees Baggerman and Wout-Jan Louwaars, with no disclosed outside investors and operating as a privately held Dutch BV.

BFC is currently executing a notable growth phase, recruiting approximately 11 additional regulatory, quality, and pharmacovigilance professionals, which would nearly double its consulting headcount. The firm has no proprietary software platform, technology product, or AI/ML capability — its deliverable is human advisory capacity sold on a time-and-materials or project basis. Pricing, contract structures, and client billing rates are not publicly disclosed.

Name

BFC

Legal name

Baggerman Farma Consult BV

Website

https://bfc.nl

Company type

Private

Founded year

1987

Operating status

Operating

Short description

Baggerman Farma Consult BV (BFC) is a Dutch boutique life sciences consultancy founded in 1987, providing Regulatory Affairs, Quality Affairs, and Pharmacovigilance advisory services on a "Regulatory as a Service" basis to pharmaceutical, medical device, and healthcare clients across Europe.

Ownership category

akta.pro rank

Headquarters

HQ city

Eindhoven

HQ country

Netherlands

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Revenue model

1. Consultancy Services: BFC provides professional consultancy services in Quality Affairs, Regulatory Affairs, Pharmacovigilance, and Market Access. Services are delivered as short-term projects (weeks or months) with clearly defined deliverables, supporting pharmaceutical compliance needs from molecule to commercialization.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

BFC (Baggerman Farma Consult BV) is a boutique consultancy delivering Quality, Regulatory, and Pharmacovigilance services to pharmaceutical, medical device, and healthcare organizations. Operating on a Regulatory as a Service (RaaS) model, BFC provides short-term, project-based engagements covering EU regulatory procedures, GMP/GDP/ISO 13485 quality systems, GVP-compliant pharmacovigilance, and EU market access licensing.

Product overview

BFC is a boutique consultancy company offering a unified portfolio of four core service areas: Regulatory Affairs, Quality Affairs, Pharmacovigilance, and a Market Access Program. The company operates on a Regulatory as a Service (RaaS) business model, providing specialized short-term consultancy services to pharmaceutical companies, medical device manufacturers, and healthcare organizations. Core offerings include regulatory procedure management (Centralized, DCP, MRP procedures), quality system design and implementation (GMP/GDP/ISO 13485), pharmacovigilance services (GVP compliance, adverse reaction monitoring, PSUR/RMP), and EU market access support (MIA licensing, QP services, supply chain design). The company employs 12 highly experienced consultants and has served clients since 1987.

Differentiator

Problem solved

Functional benefit

Products and services

• Regulatory Affairs Provides regulatory guidance and support for human medicinal products including EU Centralized Procedures, Decentralized Procedures (DCP), and Mutual Recognition Procedures (MRP). Also covers CE marking for medical devices, cosmetics, biocides, and food supplements. Aimed at pharmaceutical companies, medical device manufacturers, and healthcare organizations needing EU regulatory pathway management.
• Quality Affairs Designs and implements quality systems for pharmaceutical production facilities (EU-GMP), distribution facilities (EU-GDP), medical device companies (ISO/EN-13485), and OTC/Food companies (HACCP). Includes Qualified/Responsible Person services and audit services. Aimed at pharmaceutical manufacturers, distributors, medical device companies, and OTC/food firms.
• Pharmacovigilance Provides expert safety consulting including collection and recording of suspected adverse reactions, GVP compliance support, Local Drug Safety Unit (DSU) services, QPPV system coverage, PSUR and RMP writing, signal detection, and Eudravigilance/XEVMPD submissions. Aimed at pharmaceutical companies requiring GVP-compliant safety operations.
• Market Access Program EU-focused program supporting pharmaceutical product launches including MIA license application support, Qualified Person provision, supply chain design, GDP license compliance, and commercialization strategy setup. Aimed at pharmaceutical companies launching or expanding into the EU market.
• Qualified Person (QP) Services Provides trained and adequately qualified QPs for importer license requirements and release of medicines to the EU market, as required by pharmaceutical licensing regulations. Aimed at pharmaceutical companies needing a Qualified Person for EU import and release of medicines.
• Medical Information Services Outsourced medical information function handling medical enquiries and providing product information support as part of pharmacovigilance operations. Aimed at pharmaceutical companies needing medical information handling as part of their safety operations.
• e-CTD Publishing In-house regulatory support activity for electronic Common Technical Document publishing, medical translations, QC reading of artworks, and variations management. Aimed at pharmaceutical companies submitting EU regulatory filings.

Quantifiable outcome

• Deliver work ahead of schedule by balancing quality with speed of delivery
• +1 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• EUdraCON NetworkcoreStrategic or Co-development PartnerBFC has partnerships with consultancy companies throughout Europe within the EUdraCON network. This partnership enables BFC to support regulatory affairs matters across all possible EU directives and provide comprehensive regulatory process support throughout Europe.

Scale indicators3 records

Recent moves4 records

Expansion highlights4 records

Direct peers

• QbD Group: QbD Group is a Benelux-headquartered life sciences consultancy providing quality, regulatory, and validation services to pharma and medical device companies. Geographically and service-wise it is one of BFC's closest direct competitors in the EU RA/QA market.
• Arriello: Arriello is a European life sciences consulting firm specializing in regulatory affairs, pharmacovigilance, and quality compliance for pharma and biotech. Its service portfolio and EU focus mirror BFC's boutique positioning.
• PharmaLex: PharmaLex is a closely comparable EU-headquartered boutique regulatory, quality, and pharmacovigilance consultancy serving pharma and biotech clients. Acquired by Cencora (formerly AmerisourceBergen), it directly competes with BFC in the same RaaS-style service lines across EU regulatory procedures, GVP, and market access support.
• ProPharma Group: ProPharma is a global pharma consulting firm offering regulatory affairs, quality compliance, pharmacovigilance, and medical information services — essentially the same four-pillar service portfolio as BFC. It serves pharma and medical device manufacturers with similar boutique-style engagement models, making it a highly comparable direct peer.
• Voisin Consulting Life Sciences: Voisin Consulting Life Sciences is a European boutique consultancy providing regulatory, clinical, and quality services to life sciences companies. Like BFC, it focuses on expert-led consulting engagements for pharma and medical device clients across EU regulatory pathways.
• NDA Group: NDA Group is an EU-based regulatory and quality consulting firm supporting pharma and biotech clients with MAA preparation, scientific advice, and CMC services. It is directly comparable to BFC's regulatory affairs service line and serves a similar startup-to-mid-pharma client base.

Broad incumbents

• Parexel: Parexel is one of the largest global CROs with substantial regulatory consulting capabilities. It serves pharma clients needing EU regulatory and pharmacovigilance support but competes at the enterprise scale rather than boutique model that defines BFC.
• ICON plc: ICON is a global CRO offering regulatory and pharmacovigilance services alongside its clinical core. It competes with BFC for pharma clients needing regulatory support but as part of a much broader service portfolio rather than as a focused boutique.
• IQVIA: IQVIA is the largest life sciences services platform globally, offering technology-enabled regulatory, quality, and pharmacovigilance services. It is not a direct boutique competitor but represents the scaled-incumbent alternative that pharma clients weigh against BFC.

Emerging players

• Pharma To Market: Pharma To Market is a smaller EU consultancy supporting pharma market access, regulatory, and commercialization services. It overlaps with BFC's Market Access Program but with narrower geographic and service scope.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles14 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BFC